Enzyme insight could lead to new treatment approach for diabetic patients

Enzyme insight could lead to new treatment approach for diabetic patients

Enzyme insight could lead to new treatment approach for diabetic patients

Research led by the Centenary Institute has discovered that the lack of an enzyme in the liver called sphingosine kinase 2 results in pronounced insulin resistance and glucose intolerance, both symptoms of early stage type 2 diabetes.